» Articles » PMID: 36304045

Ovarian Fragmentation and AKT Stimulation for Expansion of Fertile Lifespan

Overview
Date 2022 Oct 28
PMID 36304045
Authors
Affiliations
Soon will be listed here.
Abstract

Since the first baby was born after fertilization, the female infertility treatment has been well-developed, yielding successful outcomes. However, successful pregnancies for patients with premature ovarian insufficiency and diminished ovarian reserve are still difficult and diverse therapies have been suggested to improve the chances to have their genetically linked offspring. Recent studies demonstrated that the activation Akt pathway by using a phosphatase and tensin homolog enzyme inhibitor and a phosphatidylinositol-3 kinase stimulator can activate dormant primordial follicles in both mice and human ovaries. Subsequent researches suggested that the disruption of Hippo signaling pathway by ovarian fragmentation increased the expression of downstream growth factors and secondary follicle growth. Based on the combination of ovarian fragmentation and Akt stimulation, the activation (IVA) approach has resulted in successful follicle growth and live births in premature ovarian insufficiency patients. The approach with disruption of Hippo signaling only was also shown to be effective for treating poor ovarian responders with diminishing ovarian reserve, including advanced age women and cancer patients undergoing sterilizing treatments. This review aims to summarize the effectiveness of ovarian fragmentation and Akt stimulation on follicle growth and the potential of IVA in extending female fertile lifespan.

Citing Articles

Microfluidic chips in female reproduction: a systematic review of status, advances, and challenges.

Wu T, Yan J, Nie K, Chen Y, Wu Y, Wang S Theranostics. 2024; 14(11):4352-4374.

PMID: 39113805 PMC: 11303079. DOI: 10.7150/thno.97301.


Oocyte aging in comparison to stem cells in mice.

Nagamatsu G Front Aging. 2023; 4:1158510.

PMID: 37114094 PMC: 10126682. DOI: 10.3389/fragi.2023.1158510.

References
1.
Macklon K, Jensen A, Loft A, Ernst E, Andersen C . Treatment history and outcome of 24 deliveries worldwide after autotransplantation of cryopreserved ovarian tissue, including two new Danish deliveries years after autotransplantation. J Assist Reprod Genet. 2014; 31(11):1557-64. PMC: 4389945. DOI: 10.1007/s10815-014-0331-z. View

2.
Cheng Y, Feng Y, Jansson L, Sato Y, Deguchi M, Kawamura K . Actin polymerization-enhancing drugs promote ovarian follicle growth mediated by the Hippo signaling effector YAP. FASEB J. 2015; 29(6):2423-30. PMC: 4447223. DOI: 10.1096/fj.14-267856. View

3.
Bertoldo M, Walters K, Ledger W, Gilchrist R, Mermillod P, Locatelli Y . In-vitro regulation of primordial follicle activation: challenges for fertility preservation strategies. Reprod Biomed Online. 2018; 36(5):491-499. DOI: 10.1016/j.rbmo.2018.01.014. View

4.
Dolmans M, Martinez-Madrid B, Gadisseux E, Guiot Y, Yuan W, Torre A . Short-term transplantation of isolated human ovarian follicles and cortical tissue into nude mice. Reproduction. 2007; 134(2):253-62. DOI: 10.1530/REP-07-0131. View

5.
Aboura A, Dupas C, Tachdjian G, Portnoi M, Bourcigaux N, Dewailly D . Array comparative genomic hybridization profiling analysis reveals deoxyribonucleic acid copy number variations associated with premature ovarian failure. J Clin Endocrinol Metab. 2009; 94(11):4540-6. DOI: 10.1210/jc.2009-0186. View